In the BioHarmony Drug Report Database
Pyridostigmine
Mestinon, Pyridostigmine Bromide, Regonol (pyridostigmine) is a small molecule pharmaceutical. Pyridostigmine was first approved as Mestinon on 1982-01-01. It is used to treat drug-induced abnormalities and myasthenia gravis in the USA. It is known to target acetylcholinesterase and cholinesterase.
Trade Name
|
Mestinon, Pyridostigmine Bromide, Regonol |
|---|---|
Common Name
|
pyridostigmine |
ChEMBL ID
|
CHEMBL1115 |
Indication
|
drug-induced abnormalities, myasthenia gravis |
Drug Class
|
Cholinesterase inhibitors (physostigmine type) |
Image (chem structure or protein)